FdaApplication

NDA 020233

Back to search

Identifiers

Properties

PropertyValue
applicant_nameASTRAZENECA LP
application_typeNDA
approval_date1994-02-14

Products (1)

ProductActive ingredientStrengthDosage form
RHINOCORTBUDESONIDE0.032MG/INHAEROSOL, METERED;NASAL

1 product